These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 27725294)
1. Aberrant expression of miR-9 in benign and malignant breast tumors. Hasanzadeh A; Mesrian Tanha H; Ghaedi K; Madani M Mol Cell Probes; 2016 Oct; 30(5):279-284. PubMed ID: 27725294 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-19b in hormone receptor-positive/HER2-negative breast cancer. Maleki E; Ghaedi K; Shahanipoor K; Karimi Kurdistani Z APMIS; 2018 Apr; 126(4):303-308. PubMed ID: 29575198 [TBL] [Abstract][Full Text] [Related]
3. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women. Orangi E; Motovali-Bashi M Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908 [TBL] [Abstract][Full Text] [Related]
5. microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53. Wang F; Lv P; Liu X; Zhu M; Qiu X Int J Mol Med; 2015 May; 35(5):1395-402. PubMed ID: 25738546 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
7. Analysis of serum genome-wide microRNAs for breast cancer detection. Wu Q; Wang C; Lu Z; Guo L; Ge Q Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599 [TBL] [Abstract][Full Text] [Related]
8. Role of miR-101 in pheochromocytoma patients with SDHD mutation. Zong L; Meng L; Shi R Int J Clin Exp Pathol; 2015; 8(2):1545-54. PubMed ID: 25973039 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191 [TBL] [Abstract][Full Text] [Related]
10. Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study). Abak A; Amini S; Estiar MA; Montazeri V; Sakhinia E; Abhari A Clin Lab; 2018 Jan; 64(1):169-175. PubMed ID: 29479893 [TBL] [Abstract][Full Text] [Related]
11. Decreased Expression of Bioinformatically Predicted piwil2-targetting microRNAs, miR-1267 and miR-2276 in Breast Cancer. Torkashvand S; Damavandi Z; Mirzaei B; Tavallaei M; Vasei M; Mowla SJ Arch Iran Med; 2016 Jun; 19(6):420-5. PubMed ID: 27293058 [TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer. Sevinc ED; Cecener G; Ak S; Tunca B; Egeli U; Gokgoz S; Tolunay S; Tasdelen I Gene; 2016 Sep; 590(2):278-84. PubMed ID: 27236032 [TBL] [Abstract][Full Text] [Related]
13. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer. Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer. Elghoroury EA; Abdelghafar EE; Kamel S; Awadallah E; Shalaby A; El-Saeed GSM; Mahmoud E; Kamel MM; Abobakr A; Yousef RN PLoS One; 2024; 19(5):e0298536. PubMed ID: 38820252 [TBL] [Abstract][Full Text] [Related]
15. The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study. Tang W; Li GS; Li JD; Pan WY; Shi Q; Xiong DD; Mo CH; Zeng JJ; Chen G; Feng ZB; Huang SN; Rong MH Pathol Res Pract; 2020 Jan; 216(1):152754. PubMed ID: 31787478 [TBL] [Abstract][Full Text] [Related]
16. Expression and Tissue Distribution of MicroRNA-21 in Malignant and Benign Breast Tissues>. Hug KA; Anthony L; Eldeiry D; Benson J; Wheeler E; Mousa S; Shi B Anticancer Res; 2015 Jun; 35(6):3175-83. PubMed ID: 26026077 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer. Johannessen C; Moi L; Kiselev Y; Pedersen MI; Dalen SM; Braaten T; Busund LT PLoS One; 2017; 12(10):e0186658. PubMed ID: 29073169 [TBL] [Abstract][Full Text] [Related]
18. Expression level of miR-93 in formalin-fixed paraffin-embedded tissues of breast cancer patients. Deng ZQ; Qian J; Liu FQ; Lin J; Shao R; Yin JY; Tang Q; Zhang M; He L Genet Test Mol Biomarkers; 2014 May; 18(5):366-70. PubMed ID: 24606013 [TBL] [Abstract][Full Text] [Related]
19. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023 [TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]